Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference

Erasca (Nasdaq: ERAS) announced it will present at the 44th Annual J.P.

Rhea-AI Summary

Erasca (Nasdaq: ERAS) announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.

Management will present on Tuesday, January 13, 2026 at 1:30 PM PT, participate in one-on-one investor meetings, and provide a live audio webcast at Erasca.com/events. An archived replay will be available for 30 days after the webcast.

Argus Jan 6 session

+4.01% close to close Open Argus

Details

News Market Reaction – ERAS

On Jan 6, the day this news came out, ERAS closed 4.01% above the previous close.

Data tracked by StockTitan Argus for the Jan 6 session.

Market Context

This announcement highlights Erasca’s participation in the 44th J.P. Morgan Healthcare Conference on...

Analysis

This announcement highlights Erasca’s participation in the 44th J.P. Morgan Healthcare Conference on January 13, 2026, continuing a pattern of active engagement at major investor events. Past updates combined conferences with patent, pipeline and financial disclosures, including cash runway into H2 2028. Investors may watch for any new commentary around the RAS/MAPK-focused pipeline, use of the $500,000,000 shelf, and timing of upcoming clinical data readouts.

Key Figures

Conference edition: 44th Annual Presentation date: January 13, 2026 Presentation time: 1:30 pm Pacific Time +1 more

Conference edition

44th Annual

J.P. Morgan Healthcare Conference

Presentation date

January 13, 2026

Company presentation at J.P. Morgan conference

Presentation time

1:30 pm Pacific Time

Scheduled management presentation slot

Replay duration

30 days

Archived webcast availability at Erasca.com/events

Historical Context

5 past events · Latest: Nov 25

5 events

1. Nov 25

   Investor conference

   24h Move

   +6.2%

   Evercore healthcare conference fireside chat and webcast announcement.

2. Nov 12

   Earnings update

   24h Move

   +12.3%

   Q3 2025 business update, patent issuance, cash runway into H2 2028.

3. Nov 06

   Patent issuance

   24h Move

   +1.8%

   U.S. patent issued covering pan‑RAS molecular glue ERAS‑0015.

4. Nov 04

   Conference schedule

   24h Move

   -2.9%

   Multiple November 2025 investor conferences and fireside chats.

5. Sep 02

   Investor conference

   24h Move

   +1.9%

   Morgan Stanley global healthcare conference presentation and meetings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ras/mapk pathway, oncology

2 terms

ras/mapk pathway medical

"therapies for patients with RAS/MAPK pathway-driven cancers"

A cellular signaling route that acts like a chain of command inside cells to tell them when to grow, divide, or die; when parts of this RAS/MAPK pathway are stuck “on,” it can drive uncontrolled cell growth that leads to cancer. Investors care because drugs, tests, or diagnostics that target or measure this pathway can become valuable products, affect drug approval chances, and change a company’s revenue or risk profile much like fixing a critical production line in a factory.

oncology medical

"a clinical-stage precision oncology company singularly focused"

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 44^th Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis in San Francisco, California. Management will present on Tuesday, January 13, 2026, at 1:30 pm Pacific Time and will also participate in one-on-one investor meetings.

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Erasca (ERAS) presenting at the J.P. Morgan Healthcare Conference?

Erasca will present on Tuesday, January 13, 2026 at 1:30 PM PT.

How can investors watch Erasca's (ERAS) presentation on January 13, 2026?

A live audio webcast will be available at Erasca.com/events, with a replay archived for 30 days.

Will Erasca (ERAS) hold investor meetings at the 44th J.P. Morgan Healthcare Conference?

Yes, management will participate in one-on-one investor meetings during the conference.

Where is the 44th Annual J.P. Morgan Healthcare Conference being held for Erasca's presentation?

The conference is at the Westin St. Francis in San Francisco, California.

What topics will Erasca (ERAS) cover at the January 13, 2026 presentation?

Management will discuss the company's progress and outlook on its RAS/MAPK pathway-driven oncology programs.